<DOC>
	<DOCNO>NCT01526330</DOCNO>
	<brief_summary>The objective study assess safety tolerability YH14618 24 week follow-up period single administration patient degenerative disc disease .</brief_summary>
	<brief_title>Safety , Tolerability Efficacy YH14618 Patients With Degenerative Disc Disease</brief_title>
	<detailed_description />
	<mesh_term>Spinal Diseases</mesh_term>
	<mesh_term>Intervertebral Disc Degeneration</mesh_term>
	<criteria>Have sign write informed consent voluntarily , prior procedure Degenerative disc disease patient age 20 year Have one symptomatic lumbar level ( L1~S1 ) confirm use radiology ( Xray , MRI and/or discogram/CT ) Have diagnose 2~3 degree MRI index modify thompson classification Oswestry diability index ( ODI ) 30 great Visual analog scale ( VAS ) 4 great Subjects unable radiological examination Have history neurological disease , herniated lumbar disc , compression fracture lumbar spinal surgery Sacroiliac joint dysfunction Have treat drug pain control within 7 day prior first administration Hypersensitivity drug Pregnant woman , nurse mother subject agree assign contraception study Participated clinical trial within 30 day prior first administration</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Degenerative disc disease</keyword>
	<keyword>YH14618</keyword>
	<keyword>Penial 2000</keyword>
	<keyword>Penial 2K</keyword>
</DOC>